Infection after Acute Ischemic Stroke: Risk Factors, Biomarkers, and Outcome

侯欣妤、洪啟偉、葉昭宏、黃建程、蘇世斌、陳思豪（2013）。Analysis of Prognosis and Risk Factors of Recurrent Ischemic Stroke。台灣家庭醫學雜誌，23(2)，69-82。https://www.airitilibrary.com/Article/Detail?DocID=16823281-201306-201402240031-201402240031-69-82
Liu, A. B., Lin, C. H., Lin, R., & Chang, T. W. (1993). Hemodilution for Acute Ischemic Stroke: Four Empirical Cases Report. 慈濟醫學雜誌, 5(4), 295-301. https://doi.org/10.6440/TZUCMJ.199312.0295
顏正昌、盧玉強、萬樹人、林清煌、張運德、羅崇誠、陳立偉、高志翔（2010）。Improving Experiences of Thrombolytic Therapy in Acute Ischemic Stroke。重症醫學雜誌，11(4)，231-238。https://doi.org/10.30035/TCCM.201012.0001
Hjalmarsson, C., Manhem, K., Bokemark, L., & Andersson, B. (2014). The Role of Prestroke Glycemic Control on Severity and Outcome of Acute Ischemic Stroke. Stroke Research and Treatment, (2014), 210-215. https://doi.org/10.1155/2014/694569
連立明、陳俊榮、陳威宏、葉建宏、汪漢澄、許維志、徐榮隆、吳令治、謝欣如、邱浩彰（2000）。Preliminary Experience of Treating Acute Ischemic Stroke with Intravenous Tissue Plasminogen Activator。台灣醫學，4(4)，379-387。https://doi.org/10.6320/FJM.2000.4(4).02